{"id":"https://openalex.org/W2000779382","doi":"https://doi.org/10.1158/0008-5472.can-08-0237","title":"Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone","display_name":"Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of Sagopilone","publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W2000779382","doi":"https://doi.org/10.1158/0008-5472.can-08-0237","mag":"2000779382","pmid":"https://pubmed.ncbi.nlm.nih.gov/18593931"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-08-0237","doi":"https://doi.org/10.1158/0008-5472.can-08-0237","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-08-0237","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/13/5301/2596885/5301.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/cancerres/article-pdf/68/13/5301/2596885/5301.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002682008","display_name":"Jens Hoffmann","orcid":"https://orcid.org/0000-0003-3880-1658","observed_orcids":["https://orcid.org/0000-0003-3880-1658"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Hoffmann","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067656240","display_name":"Ilio Vitale","orcid":"https://orcid.org/0000-0002-5918-1841","observed_orcids":["https://orcid.org/0000-0002-5918-1841"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Ilio Vitale","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057986458","display_name":"Bernd Buchmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Bernd Buchmann","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071827163","display_name":"Lorenzo Galluzzi","orcid":"https://orcid.org/0000-0003-2257-8500","observed_orcids":["https://orcid.org/0000-0003-2257-8500"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lorenzo Galluzzi","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000970677","display_name":"Wolfgang Schwede","orcid":"https://orcid.org/0000-0003-3128-2971","observed_orcids":["https://orcid.org/0000-0003-3128-2971"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Schwede","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074355427","display_name":"Laura Senovilla","orcid":"https://orcid.org/0000-0001-6887-2436","observed_orcids":["https://orcid.org/0000-0001-6887-2436"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laura Senovilla","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052871202","display_name":"Werner Skuballa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Werner Skuballa","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sonia Vivet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sonia Vivet","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109314824","display_name":"Rosemarie B. Lichtner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Rosemarie B. Lichtner","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010245558","display_name":"Jose Miguel Vicencio","orcid":"https://orcid.org/0000-0002-1811-9275","observed_orcids":["https://orcid.org/0000-0002-1811-9275"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jose\u0301 M. Vicencio","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037435178","display_name":"Theocharis Panaretakis","orcid":"https://orcid.org/0000-0001-5754-6950","observed_orcids":["https://orcid.org/0000-0001-5754-6950","https://orcid.org/0009-0008-3265-5040"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Theocharis Panaretakis","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040107084","display_name":"Gerhard Siemeister","orcid":"https://orcid.org/0000-0002-4712-0531","observed_orcids":["https://orcid.org/0000-0002-4712-0531"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Gerhard Siemeister","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024499062","display_name":"Hermann Lage","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hermann Lage","raw_affiliation_strings":["2Charite\u0301, Institute of Pathology, Humboldt University; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Charite\u0301, Institute of Pathology, Humboldt University; and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042189242","display_name":"Lisa Nanty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lisa Nanty","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015618150","display_name":"Stefanie Hammer","orcid":"https://orcid.org/0000-0002-5635-9878","observed_orcids":["https://orcid.org/0000-0002-5635-9878"]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Stefanie Hammer","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053028986","display_name":"Kevin Mittelstaedt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Kevin Mittelstaedt","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006461113","display_name":"Sebastian Winsel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]},{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sebastian Winsel","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;","3Institute for Chemistry and Biochemistry, Freie Universita\u0308t, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"3Institute for Chemistry and Biochemistry, Freie Universita\u0308t, Berlin, Germany;","institution_ids":["https://openalex.org/I75951250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014499840","display_name":"Julia Eschenbrenner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]},{"id":"https://openalex.org/I75951250","display_name":"Freie Universit\u00e4t Berlin","ror":"https://ror.org/046ak2485","country_code":"DE","type":"education","lineage":["https://openalex.org/I75951250"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Eschenbrenner","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;","3Institute for Chemistry and Biochemistry, Freie Universita\u0308t, Berlin, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]},{"raw_affiliation_string":"3Institute for Chemistry and Biochemistry, Freie Universita\u0308t, Berlin, Germany;","institution_ids":["https://openalex.org/I75951250"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044366070","display_name":"Maria Castedo","orcid":"https://orcid.org/0000-0001-6855-3451","observed_orcids":["https://orcid.org/0000-0001-6855-3451"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Maria Castedo","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045098402","display_name":"Carine Demarche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Carine Demarche","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034559941","display_name":"Ulrich Klar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I67348948","display_name":"Bayer (Germany)","ror":"https://ror.org/04hmn8g73","country_code":"DE","type":"company","lineage":["https://openalex.org/I67348948"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Ulrich Klar","raw_affiliation_strings":["1Bayer Schering Pharma AG, TRG Oncology;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Bayer Schering Pharma AG, TRG Oncology;","institution_ids":["https://openalex.org/I67348948"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075296559","display_name":"Guido Kroemer","orcid":"https://orcid.org/0000-0002-9334-4405","observed_orcids":["https://orcid.org/0000-0002-9334-4405"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Guido Kroemer","raw_affiliation_strings":["4Institut National de la Sante et de la Recherche Medicale, U848;","5Institut Gustave Roussy; and","6Universite\u0301 Paris-Sud 11, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut National de la Sante et de la Recherche Medicale, U848;","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"5Institut Gustave Roussy; and","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"6Universite\u0301 Paris-Sud 11, Villejuif, France","institution_ids":["https://openalex.org/I102197404"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.3783,"has_fulltext":true,"cited_by_count":103,"citation_normalized_percentile":{"value":0.97300695,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"68","issue":"13","first_page":"5301","last_page":"5308"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.8281000256538391,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.8281000256538391,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.14890000224113464,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sagopilone","display_name":"sagopilone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/epothilones","display_name":"epothilones","score":0.8790000081062317},{"id":"https://openalex.org/keywords/microtubule-stabilization","display_name":"microtubule stabilization","score":0.8320000171661377},{"id":"https://openalex.org/keywords/microtubule-polymerization","display_name":"microtubule assembly","score":0.796999990940094},{"id":"https://openalex.org/keywords/cellular-pharmacokinetics","display_name":"cellular pharmacokinetics","score":0.8009999990463257},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.640999972820282},{"id":"https://openalex.org/keywords/p-glycoprotein-efflux","display_name":"P-glycoprotein efflux","score":0.7540000081062317},{"id":"https://openalex.org/keywords/paclitaxel-resistance","display_name":"paclitaxel resistance","score":0.8370000123977661},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5239999890327454},{"id":"https://openalex.org/keywords/mitochondrial-apoptosis","display_name":"mitochondrial apoptosis","score":0.7979999780654907},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.8100000023841858},{"id":"https://openalex.org/keywords/chk1","display_name":"Chk1","score":0.9660000205039978},{"id":"https://openalex.org/keywords/mitotic-arrest","display_name":"mitotic arrest","score":0.7680000066757202},{"id":"https://openalex.org/keywords/multinucleation","display_name":"multinucleation","score":0.9110000133514404},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.492000013589859},{"id":"https://openalex.org/keywords/ixabepilone","display_name":"ixabepilone","score":0.7839999794960022},{"id":"https://openalex.org/keywords/patupilone","display_name":"patupilone","score":0.7570000290870667}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8463670015335083},{"id":"https://openalex.org/C2777526313","wikidata":"https://www.wikidata.org/wiki/Q408201","display_name":"Epothilone","level":2,"score":0.8278614282608032},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4960375726222992},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4810329079627991},{"id":"https://openalex.org/C84425145","wikidata":"https://www.wikidata.org/wiki/Q422492","display_name":"Tubulin","level":3,"score":0.4777480959892273},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4621354639530182},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43982887268066406},{"id":"https://openalex.org/C22615655","wikidata":"https://www.wikidata.org/wiki/Q203221","display_name":"Small interfering RNA","level":4,"score":0.43982088565826416},{"id":"https://openalex.org/C20418707","wikidata":"https://www.wikidata.org/wiki/Q189933","display_name":"Microtubule","level":2,"score":0.4349218010902405},{"id":"https://openalex.org/C2908737170","wikidata":"https://www.wikidata.org/wiki/Q408201","display_name":"Epothilones","level":2,"score":0.422323614358902},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4104543924331665},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3671085238456726},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34763723611831665},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.32820743322372437},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2539437413215637},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17814534902572632},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.14880937337875366},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006367","descriptor_name":"HeLa Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014404","descriptor_name":"Tubulin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014404","descriptor_name":"Tubulin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D034261","descriptor_name":"Epothilones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D045325","descriptor_name":"HCT116 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052160","descriptor_name":"Benzothiazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/0008-5472.can-08-0237","doi":"https://doi.org/10.1158/0008-5472.can-08-0237","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-08-0237","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/13/5301/2596885/5301.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:18593931","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18593931","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.can-08-0237","doi":"https://doi.org/10.1158/0008-5472.can-08-0237","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-08-0237","pdf_url":"https://aacrjournals.org/cancerres/article-pdf/68/13/5301/2596885/5301.pdf","source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000779382.pdf","grobid_xml":"https://content.openalex.org/works/W2000779382.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1492385768","https://openalex.org/W1525028073","https://openalex.org/W1591187753","https://openalex.org/W1963801361","https://openalex.org/W1964483580","https://openalex.org/W1972824585","https://openalex.org/W1978860052","https://openalex.org/W1981120731","https://openalex.org/W1999142756","https://openalex.org/W2003163223","https://openalex.org/W2003224526","https://openalex.org/W2021886598","https://openalex.org/W2022138045","https://openalex.org/W2024870937","https://openalex.org/W2025177979","https://openalex.org/W2025291080","https://openalex.org/W2044968828","https://openalex.org/W2071274102","https://openalex.org/W2075677078","https://openalex.org/W2084535944","https://openalex.org/W2087397818","https://openalex.org/W2089450902","https://openalex.org/W2096490067","https://openalex.org/W2099243119","https://openalex.org/W2108929767","https://openalex.org/W2111139068","https://openalex.org/W2112913657","https://openalex.org/W2132869468","https://openalex.org/W2136506672","https://openalex.org/W2147051864","https://openalex.org/W2151388261","https://openalex.org/W2151716382","https://openalex.org/W2158749015","https://openalex.org/W2160711371","https://openalex.org/W2163978496","https://openalex.org/W2165708803","https://openalex.org/W2242941443","https://openalex.org/W2285512832","https://openalex.org/W2317293859","https://openalex.org/W2620176919"],"related_works":["https://openalex.org/W2412426552","https://openalex.org/W2114912469","https://openalex.org/W1997522537","https://openalex.org/W4255463305","https://openalex.org/W2219500547","https://openalex.org/W2015674438","https://openalex.org/W2043378752","https://openalex.org/W2345741396","https://openalex.org/W2317293859","https://openalex.org/W2073369590"],"abstract_inverted_index":{"Sagopilone":[0],"(ZK-EPO)":[1],"is":[2,96,194,217,240],"the":[3,12,20,32,36,64,83,101,119,125,159,165,222,231,234],"first":[4],"fully":[5],"synthetic":[6,92],"epothilone":[7,86],"undergoing":[8],"clinical":[9],"trials":[10],"for":[11],"treatment":[13],"of":[14,40,100,118,124,136,161,164,175,204,224,237],"human":[15,205],"tumors.":[16],"Here,":[17],"we":[18],"investigate":[19],"cellular":[21],"pathways":[22],"by":[23,107,113,131,158],"which":[24,239],"sagopilone":[25,41,55,95,108,132,142,193,216],"blocks":[26],"tumor":[27],"cell":[28,184,207],"proliferation":[29],"and":[30,35,50,66,78,116,171,211],"compare":[31],"intracellular":[33],"pharmacokinetics":[34],"in":[37,74,200,209,212,220,243],"vivo":[38],"pharmacodynamics":[39],"with":[42,63,133],"other":[43,79,198],"microtubule-stabilizing":[44],"(or":[45],"tubulin-polymerizing)":[46],"agents.":[47],"Cellular":[48],"uptake":[49],"fractionation/localization":[51],"studies":[52],"revealed":[53,140],"that":[54,141],"enters":[56],"cells":[57,181],"more":[58,61,69,195],"efficiently,":[59],"associates":[60],"tightly":[62],"cytoskeleton,":[65],"polymerizes":[67],"tubulin":[68],"potently":[70],"than":[71,197],"paclitaxel.":[72,146],"Moreover,":[73],"contrast":[75],"to":[76,145,182,187],"paclitaxel":[77],"epothilones":[80,199],"[such":[81],"as":[82],"natural":[84],"product":[85],"B":[87],"(patupilone)":[88],"or":[89,178],"its":[90,188],"partially":[91],"analogue":[93],"ixabepilone],":[94],"not":[97],"a":[98,134,201,244],"substrate":[99],"P-glycoprotein":[102],"efflux":[103],"pumps.":[104],"Microtubule":[105],"stabilization":[106],"caused":[109],"mitotic":[110],"arrest,":[111],"followed":[112],"transient":[114],"multinucleation":[115],"activation":[117],"mitochondrial":[120],"apoptotic":[121],"pathway.":[122],"Profiling":[123],"proapoptotic":[126,162],"signal":[127],"transduction":[128],"pathway":[129],"induced":[130],"panel":[135,203],"small":[137],"interfering":[138],"RNAs":[139],"acts":[143],"similarly":[144],"In":[147,214],"HCT":[148],"116":[149],"colon":[150],"carcinoma":[151],"cells,":[152],"sagopilone-induced":[153,183],"apoptosis":[154],"was":[155],"partly":[156],"antagonized":[157],"knockdown":[160,174],"members":[163],"Bcl-2":[166],"family,":[167],"including":[168],"Bax,":[169],"Bak,":[170],"Puma,":[172],"whereas":[173],"Bcl-2,":[176],"Bcl-X(L),":[177],"Chk1":[179],"sensitized":[180],"death.":[185],"Related":[186],"improved":[189],"subcellular":[190],"pharmacokinetics,":[191],"however,":[192],"cytotoxic":[196],"large":[202],"cancer":[206,226],"lines":[208],"vitro":[210],"vivo.":[213],"particular,":[215],"highly":[218],"effective":[219],"reducing":[221],"growth":[223],"paclitaxel-resistant":[225],"cells.":[227],"These":[228],"results":[229],"underline":[230],"processes":[232],"behind":[233],"therapeutic":[235],"efficacy":[236],"sagopilone,":[238],"now":[241],"evaluated":[242],"broad":[245],"phase":[246],"II":[247],"program.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}